Regeneron Reports Third Quarter 2025 Financial and Operating Results
Regeneron Reports Third Quarter 2025 Financial and Operating Results
5 months ago
globenewswire.com
President Trump receives Regeneron’s “antibody cocktail” treatment
1:57
President Trump receives Regeneron’s “antibody cocktail” treatment
Oct 3, 2020
NBC News
Curious how we make our products? Learn about our Industrial Operations and Product Supply (IOPS) team, which manufactures our medicines for patients worldwide http://bit.ly/2kpbuvc | Regeneron
0:06
Curious how we make our products? Learn about our Industrial Operations and Product Supply (IOPS) team, which manufactures our medicines for patients worldwide http://bit.ly/2kpbuvc | Regeneron
570 viewsFeb 22, 2018
FacebookRegeneron
It's Clinical Trials Awareness Week and we want to thank all clinical trial participants and investigators. Without you, none of this would be possible. Learn more about our Regeneron process from our colleague Wilson. | Regeneron
1:30
It's Clinical Trials Awareness Week and we want to thank all clinical trial participants and investigators. Without you, none of this would be possible. Learn more about our Regeneron process from our colleague Wilson. | Regeneron
331.4K viewsMay 13, 2019
FacebookRegeneron
From discovery to manufacturing, we're aiming to do more for patients. | Regeneron
0:30
From discovery to manufacturing, we're aiming to do more for patients. | Regeneron
93.7K views11 months ago
FacebookRegeneron
Supporting our communities, the next generation of scientific leaders, and helping those who need it most. Learn how our philosophy of doing well by doing good guides our approach. | Regeneron
0:06
Supporting our communities, the next generation of scientific leaders, and helping those who need it most. Learn how our philosophy of doing well by doing good guides our approach. | Regeneron
174.7K views10 months ago
FacebookRegeneron
Supporting our communities, the next generation of scientific leaders, and helping those who need it most. Learn how our philosophy of doing well by doing good guides our approach. | Regeneron
0:30
Supporting our communities, the next generation of scientific leaders, and helping those who need it most. Learn how our philosophy of doing well by doing good guides our approach. | Regeneron
493.9K views1 year ago
FacebookRegeneron
0:31
Explore clinical trials to be part of the discovery. | Regeneron
10.6K viewsApr 14, 2025
FacebookRegeneron
0:09
What drives a clinical trial investigator? The chance to support progress in science for patients. | Regeneron
34.7K views6 months ago
FacebookRegeneron
0:10
A person's atopic dermatitis (AD) should not influence their career choice. That's why we're working to better address the impact of AD. | Regeneron
58.5K viewsJun 11, 2019
FacebookRegeneron
0:31
Bridging today’s limitations with tomorrow’s breakthroughs—one clinical trial at a time. | Regeneron
3.9K views6 months ago
FacebookRegeneron
1:41
What drives a clinical trial investigator? The chance to support progress in science for patients. | Regeneron
23.8K views6 months ago
FacebookRegeneron
Regeneron Shares Drop After Sales of Higher-Dose Eylea Miss Expectations
Oct 31, 2024
marketscreener.com
1:26
Talk to your doctor to see if a clinical trial is right for you. | Regeneron
222.1K viewsFeb 20, 2025
FacebookRegeneron
0:08
You are part of the future of healthcare. Learn how your involvement can help make a difference. | Regeneron
275.7K views11 months ago
FacebookRegeneron
0:07
More than 1.3 million Americans live with rheumatoid #arthritis (RA), many of whom may be experiencing ongoing symptoms that impact their daily lives. This National Arthritis Awareness Month, we are highlighting the importance of discussing uncontrolled RA symptoms with a healthcare provider. | Regeneron
47.8K viewsMay 17, 2019
FacebookRegeneron
2:00
Regeneron immunology expert, Jamie Orengo, PhD, sees firsthand the impact allergies and asthma have on daily life. She shares how we are applying our innovative technologies for investigational research into allergic diseases. For more: http://bit.ly/3aNra5T | Regeneron
3.3K viewsJul 13, 2020
FacebookRegeneron
0:56
Grounded in excellence and driven by innovation, our Industrial Operations and Product Supply team turns science into medicine. Join our team. | Regeneron
47.1K viewsSep 24, 2023
FacebookRegeneron
Palm Beach County man, 29, praises antibody treatment after COVID-19 breakthrough case
Sep 14, 2021
wptv.com
0:29
Asthma, nasal polyps and atopic dermatitis may be connected. Visit us alongside Sanofi Genzyme at the European Academy of Allergy and Clinical Immunology congress to learn more about the connection between these seemingly unrelated diseases. | Regeneron
10.7K viewsJun 3, 2019
FacebookRegeneron
0:20
At Regeneron, our science-first mindset guides every decision as we work to meaningfully improve the lives of people with blood cancer. Karen Rodriguez Lorenc, MD, VP, Therapeutic Area Lead for Hematology Oncology, shares how we are following the science to advance research. Hear more from Karen and our other leaders: https://bit.ly/4jz4N7e | Regeneron
69.1K views10 months ago
FacebookRegeneron
Spectrum Health partnering with Regeneron on trial for COVID-19 'antibody cocktail'
Oct 29, 2020
fox17online.com
0:15
We’re using CRISPR “knock-in” and “knock-out” technology inside the body to potentially tackle difficult-to-treat genetic conditions. | Regeneron
420.7K viewsOct 26, 2023
FacebookRegeneron
2:25
Timeline: What we know about Regeneron's antibody cocktail that was given to President Trump
Oct 2, 2020
khou.com
2:49
Regeneron Pharmaceuticals will develop and release a “next generation” antibody treatment against the omicron variant early next year after the company said its current antibody cocktail loses potency against the new Covid variant, as the U.S. races to curb a surge of cases across the country. Read More: https://www.forbes.com/sites/annakaplan/2021/12/16/regeneron-developing-new-antibody-covid-cocktail-current-treatment-less-effective-against-omicron/?sh=33969eb0221f&utm_source=FBPAGE&utm_medium
2.4K viewsDec 16, 2021
FacebookForbes
Regeneron Pharmaceuticals to Have Multiple Pipeline Updates in 2026, BofA Says
3 months ago
marketscreener.com
2:13
FDA approves Regeneron’s Covid-19 antibody treatment
Nov 22, 2020
NBC News
2:55
Innovative science demands Diversity, Equity and Inclusion (DEI). That’s why our strategy is rooted in the understanding that DEI drives a better workplace, which drives better science, and that better science drives to a better world for everyone. We believe that fostering an inclusive culture and embracing diverse voices improves our ability to fulfill our mission of using the power of science to bring new medicines to patients. Read more about our progress in our first Diversity, Equity and I
286 viewsApr 26, 2023
FacebookRegeneron
0:32
How do we turn complex technology challenges into simpler solutions for patients? By designing with intention to remove bottlenecks and build platforms that can adapt across diseases. This approach is guided by our co-founder, President, and Chief Scientific Officer, George D. Yancopoulos, whose five principles of radical innovation shape how we think, design, and build. Created to cut through complexity, our proprietary Veloci-Bi® technology allows for production of bispecific antibodies, which
27.9K views3 months ago
FacebookRegeneron
0:36
Since our earliest days, we’ve believed that transforming human health takes bold scientific ambition and a deep sense of responsibility. At Regeneron, we pursue breakthrough science and technology with a long-term view, and measure success not just by progress in the lab, but by the impact we have on each patient, colleague and shareholder. Science drives our work, and responsibility fuels it. By staying focused on what matters most to our stakeholders, we’re building a resilient, responsible b
771 views11 months ago
FacebookRegeneron
See more